Education
About Us
Working with TipRanks
Follow Us
Zim Laboratories Ltd. (IN:ZIMLAB)
:ZIMLAB
RESEARCH TOOLSreports
Total Valuation
Zim Laboratories Ltd. has a market cap or net worth of ₹3.61B. The enterprise value is ₹5.06B.
Market Cap₹3.61B
Enterprise Value₹5.06B
Share Statistics
Zim Laboratories Ltd. has 48,725,815 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding48,725,815
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Zim Laboratories Ltd.’s return on equity (ROE) is 0.05 and return on invested capital (ROIC) is 4.19%.
Return on Equity (ROE)0.05
Return on Assets (ROA)0.03
Return on Invested Capital (ROIC)4.19%
Return on Capital Employed (ROCE)0.08
Revenue Per Employee6.73M
Profits Per Employee323.91K
Employee Count556
Asset Turnover0.80
Inventory Turnover2.88
Valuation Ratios
The current PE Ratio of Zim Laboratories Ltd. is 38.4. Zim Laboratories Ltd.’s PEG ratio is ―.
PE Ratio38.4
PS Ratio―
PB Ratio―
Price to Fair Value1.62
Price to FCF―
Price to Operating Cash Flow0.00
PEG Ratio―
Income Statement
In the last 12 months, Zim Laboratories Ltd. had revenue of 3.74B and earned 121.65M in profits. Earnings per share was 2.50.
Revenue3.74B
Gross Profit730.04M
Operating Income236.13M
Pretax Income180.09M
Net Income121.65M
EBITDA495.11M
Earnings Per Share (EPS)2.50
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Zim Laboratories Ltd. pays an annual dividend of ₹0.167, resulting in a dividend yield of ―
Dividend Per Share₹0.167
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.86
52-Week Price Change-34.76%
50-Day Moving Average102.27
200-Day Moving Average99.06
Relative Strength Index (RSI)26.54
Average Volume (3m)23.63K
Important Dates
Zim Laboratories Ltd. upcoming earnings date is Nov 4, 2025, TBA (Confirmed).
Last Earnings DateAug 7, 2025
Next Earnings DateNov 4, 2025
Ex-Dividend DateSep 19, 2019
Financial Position
Zim Laboratories Ltd. as a current ratio of 1.39, with Debt / Equity ratio of 46.70%
Current Ratio1.39
Quick Ratio0.87
Debt to Market Cap0.27
Net Debt to EBITDA2.34
Interest Coverage Ratio2.07
Taxes
In the past 12 months, Zim Laboratories Ltd. has paid 58.44M in taxes.
Income Tax58.44M
Effective Tax Rate0.32
Enterprise Valuation
Zim Laboratories Ltd. EV to EBITDA ratio is 10.60, with an EV/FCF ratio of 1.47K.
EV to Sales1.38
EV to EBITDA10.60
EV to Free Cash Flow1.47K
EV to Operating Cash Flow12.75
Balance Sheet
Zim Laboratories Ltd. has ₹27.99M in cash and marketable securities with ₹1.18B in debt, giving a net cash position of ₹1.15B billion.
Cash & Marketable Securities₹27.99M
Total Debt₹1.18B
Net Cash₹1.15B
Net Cash Per Share₹23.60
Tangible Book Value Per Share₹45.19
Margins
Gross margin is 50.58%, with operating margin of 6.23%, and net profit margin of 3.21%.
Gross Margin50.58%
Operating Margin6.23%
Pretax Margin4.75%
Net Profit Margin3.21%
EBITDA Margin13.06%
EBIT Margin7.76%
Analyst Forecast
The average price target for Zim Laboratories Ltd. is ₹82.00, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target₹82.00
Price Target Upside10.74% Upside
Analyst ConsensusHold
Analyst Count1
Revenue Growth Forecast-3.36%
EPS Growth Forecast-47.58%